Municipalities across the United States are facing growing scrutiny over how they are spending the large settlement payouts derived from lawsuits against opioid manufacturers, distributors and retailers. A new database released by KFF Health News shows that more than 10,500 distinct entries track how state, county and city governments spent their opioid‑settlement dollars in 2024—some of which deviate markedly from the intended goals of addiction treatment, recovery services and prevention efforts.
The settlement money stems from dozens of lawsuits in which companies accused of contributing to the opioid crisis agreed to payout more than $50 billion over nearly two decades. The funds were stipulated for use in abatement efforts—programs designed to address addiction, overdoses and related harms. Yet the database makes clear that oversight and transparency have been inconsistent at best. Some jurisdictions are using the dollars in ways that surprised addiction specialists and public‑health advocates.
Examples of spending highlighted in the database include law‑enforcement overtime, recreational “fun run” events, administrative overhead for local governments, and other uses that fall outside the core remediation goals of addiction treatment and harm reduction. While many localities are indeed directing funds toward evidence‑based programs—such as medication‑assisted treatment, recovery housing and naloxone distribution—the mixed picture has raised alarms about whether the full potential of the settlement funds is being realized.
Health policy analysts emphasize that as the opioid crisis continues to evolve—especially with the dominance of synthetic opioids like fentanyl driving overdose deaths—these settlement proceeds present a critical opportunity. Mishandling or misallocating the funds could mean lost chances to save lives, improve access to treatment, and reduce long‑term burdens on healthcare and social‑service systems. Because state and local governments typically receive payments in tranches, early decisions about spending and governance set the tone for years of programming.
The wide discretion afforded to many jurisdictions is a double‑edged sword. On the one hand, flexibility allows local officials to adapt to regional needs, to design recovery‑oriented services or partner with community providers. On the other hand, without clear federal standards, rigorous oversight or consistent public reporting, mistakes and inefficiencies can emerge. Advocates argue that the settlement language requiring that at least 85 percent of the funds be used for opioid‑related purposes should trigger stronger enforcement and public transparency.
In some states, the oversight has been more robust. Dedicated dashboards, public‑reporting portals and legislation requiring granular disclosures offer models for better accountability. In others, reports remain vague, buried in annual budgets or difficult to locate—leaving families who have lost loved ones to overdose asking whether the money is reaching the people it was meant to help. One bereaved parent put it plainly: if there’s no one watching how the funds are spent, “then they can kind of do what they want.”
For treatment providers, community health agencies and public‐health stakeholders—particularly in states like Texas with large rural populations and rising overdose rates—the data underscore the need to engage early in planning processes. Local agencies that omit input risk being sidelined in allocations and may lose out on funds directed toward meaningful programs. Conversely, those that participate actively in oversight and grant design may help shape the trajectory of spending toward proven practices in addiction treatment, recovery support and prevention.
Looking ahead, the question is whether the settlement funds will translate into measurable improvements in access to care, reductions in overdose deaths and strengthened community resilience—or whether they will become another pot of loosely tracked dollars that fails to live up to its promise. Realizing the former will require stronger transparency, sharper auditing, clearer programmatic boundaries and community engagement grounded in evidence. The recent database release by KFF Health News may serve as a catalyst—prompting both scrutiny and reform, as localities pivot from initial windfall to long‑term responsibility.
